Ciprofloxacin
CLINICAL USE
Antibacterial agent
DOSE IN NORMAL RENAL FUNCTION
Oral: 250–750 mg every 12 hoursIV: 100–400 mg every 12 hours
PHARMACOKINETICS
DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAnalgesics: increased risk of convulsions with NSAIDs; avoid premedication with opioid analgesicsAnticoagulants: anticoagulant effect of coumarins enhancedAntidepressants: metabolism of duloxetine inhibitedAntimalarials: manufacturer of artemether with lumefantrine advises avoid concomitant useAntipsychotics: possibly increased concentration of olanzapine and clozapineCiclosporin: variable response; no interaction seen locally; some reports of increased nephrotoxicityMuscle relaxants: tizanidine concentration increased – avoid concomitant useTacrolimus: increased levels (anecdotally) Theophylline: possibly increased risk of convulsions; increased plasma levels of theophylline
ADMINISTRATION
Reconstition
–
Route
Oral, IV
Rate of Administration
Infusion: over 30–60 minutes
Comments
Swallow tablets whole, do not chew Do not take milk, iron preparations, indigestion remedies or phosphate binders at the same time as ciprofloxacin orally
OTHER INFORMATION
Intraperitoneal ciprofloxacin in
, dose range 25 mg/L to 100 mg/LIn